Ziemann M - Search Results

1

Infectivity of blood products containing cytomegalovirus DNA: results of a lookback study in nonimmunocompromised patients.

Ziemann M, Juhl D, Brockmann C, Görg S, Hennig H. Ziemann M, et al. Transfusion. 2017 Jul;57(7):1691-1698. doi: 10.1111/trf.14105. Epub 2017 Mar 28. Transfusion. 2017. PMID: 28370032

2

Selection of whole-blood donors for hemoglobin testing by use of historical hemoglobin values.

Ziemann M, Steppat D, Brockmann C, Washington G, Kirchner H, Schlenke P. Ziemann M, et al. Transfusion. 2006 Dec;46(12):2176-83. doi: 10.1111/j.1537-2995.2006.01049.x. Transfusion. 2006. PMID: 17176332

3

High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.

Ziemann M, Krueger S, Maier AB, Unmack A, Goerg S, Hennig H. Ziemann M, et al. Transfusion. 2007 Nov;47(11):1972-83. doi: 10.1111/j.1537-2995.2007.01420.x. Transfusion. 2007. PMID: 17958525

4

Increased mortality in long-term intensive care patients with active cytomegalovirus infection.

Ziemann M, Sedemund-Adib B, Reiland P, Schmucker P, Hennig H. Ziemann M, et al. Crit Care Med. 2008 Dec;36(12):3145-50. doi: 10.1097/CCM.0b013e31818f3fc4. Crit Care Med. 2008. PMID: 18936696

5

The natural course of primary cytomegalovirus infection in blood donors.

Ziemann M, Unmack A, Steppat D, Juhl D, Görg S, Hennig H. Ziemann M, et al. Vox Sang. 2010 Jul 1;99(1):24-33. doi: 10.1111/j.1423-0410.2009.01306.x. Epub 2010 Jan 13. Vox Sang. 2010. PMID: 20074081

6

A novel set of real-time PCRs for rapid differentiation between human cytomegalovirus wild-type and highly passaged laboratory strains.

Ziemann M, Unmack A, Hennig H. Ziemann M, et al. J Virol Methods. 2010 Dec;170(1-2):155-9. doi: 10.1016/j.jviromet.2010.09.020. Epub 2010 Sep 29. J Virol Methods. 2010. PMID: 20887751

7

Evaluation of algorithms for the diagnostic assessment and the reentry of blood donors who tested reactive for antibodies against hepatitis B core antigen.

Juhl D, Luhm J, Görg S, Ziemann M, Hennig H. Juhl D, et al. Among authors: ziemann m. Transfusion. 2011 Jul;51(7):1477-85. doi: 10.1111/j.1537-2995.2010.03031.x. Epub 2011 Jan 28. Transfusion. 2011. PMID: 21276000

8

Reliability of capillary hemoglobin screening under routine conditions.

Ziemann M, Lizardo B, Geusendam G, Schlenke P. Ziemann M, et al. Transfusion. 2011 Dec;51(12):2714-9. doi: 10.1111/j.1537-2995.2011.03183.x. Epub 2011 May 20. Transfusion. 2011. PMID: 21599674

9

Prognostic value and cost-effectiveness of different screening strategies for HLA antibodies prior to kidney transplantation.

Ziemann M, Schönemann C, Bern C, Lachmann N, Nitschke M, Fricke L, Görg S. Ziemann M, et al. Clin Transplant. 2012 Jul-Aug;26(4):644-56. doi: 10.1111/j.1399-0012.2012.01615.x. Epub 2012 Mar 20. Clin Transplant. 2012. PMID: 22432638

10

Window period donations during primary cytomegalovirus infection and risk of transfusion-transmitted infections.

Ziemann M, Heuft HG, Frank K, Kraas S, Görg S, Hennig H. Ziemann M, et al. Transfusion. 2013 May;53(5):1088-94. doi: 10.1111/trf.12074. Epub 2013 Jan 16. Transfusion. 2013. PMID: 23320406

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters